International Vaccines Congress

PULSUS established in 1984, and expanded with the support from scientific societies and begins to conduct global medical and healthcare meetings. PULSUS is the publisher scientific, technical, and medical journals and magazines. With immense please and support, PULSUS is honored to announced it International Vaccines Congress, which will be going to held in Chicago, USA during July 27-28, 2017.Vaccines Adjuvant will be going to held in Amsterdam, Austria.

The global market of vaccines is expected to reach 48.03 billion by 2021 from UDD 32.24 billion in 2016 at a CAGR of 8.3%. The global market foe vaccine is broadly classified into technology, type, disease indication, end users and regions. Based on type the vaccine is segmented into two categories monovalent and multivalent vaccines. Monovalent vaccines have largest share of the market. Based on the disease indication, pneumococcal infection expected to account for largest share in global market in 2016. Based on the region the vaccine market is dominated by North America. As the need of vaccines is increasing many companies are investing in production of vaccines.

Everyone interested in the future of emerging-omics healthcare technique majorly in Vaccines is encouraged to attend. Connect with our social networking pages to get regular industry updates.

About PULSUS: PULSUS established in the year of 1984, and it is a publisher of scientific, technical, and medical journals. The headquarters of PULSUS are in London, UK and its office in Ontario, Canada and Hyderabad, India. PULSUS publishes 50+ scientific, technical, and medical journals and it is also association with 20+ International medical and scientific societies. PULSUS acquired Andrew John Publishing and openaccessjournas.com to expand publishing and conducting global medical meetings under cmesociety.com banner.